- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
July 17th, 2007
George Mason University Researchers Partner to Discover Novel Biomarkers for Exposure to Infectious Diseases
Researchers at George Mason University's National Center for Biodefense and Infectious Diseases and its Center for Applied Proteomics and Molecular Medicine are merging their expertise in host-pathogen biology, proteomics and nanotechnology to discover tissue and bloodborne markers that could be used for the early detection of exposure to infectious diseases.
Funded by the U.S. Department of Energy, these efforts may help save the lives of civilians and military forces exposed to biological weapons or other emerging infectious diseases, such as influenza and SARS.
|Related News Press|
Arrowhead to Present at Jefferies 2015 Healthcare Conference May 27th, 2015
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Detecting chemical weapons with a color-changing film January 28th, 2015
This Slinky lookalike 'hyperlens' helps us see tiny objects: The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists' ability to observe single molecules May 23rd, 2015
Nanotherapy effective in mice with multiple myeloma May 21st, 2015